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Abstract
Background
Few studies have tested the small intestine microbiota in humans, where most nutrient
digestion and absorption occur. Here, our objective was to examine the duodenal micro-
biota between obese and normal volunteers using metagenomic techniques.
Methodology/Principal Findings
We tested duodenal samples from five obese and five normal volunteers using 16S rDNA
V6 pyrosequencing and Illumina MiSeq deep sequencing. The predominant phyla of the
duodenal microbiota were Firmicutes and Actinobacteria, whereas Bacteroidetes were
absent. Obese individuals had a significant increase in anaerobic genera (p < 0.001) and a
higher abundance of genes encoding Acyl-CoA dehydrogenase (p = 0.0018) compared to
the control group. Obese individuals also had a reduced abundance of genes encoding
sucrose phosphorylase (p = 0.015) and 1,4-alpha-glucan branching enzyme (p = 0.05).
Normal weight people had significantly increased FabK (p = 0.027), and the glyceropho-
spholipid metabolism pathway revealed the presence of phospholipase A1 only in the con-
trol group (p = 0.05).
Conclusions/Significance
The duodenal microbiota of obese individuals exhibit alterations in the fatty acid and
sucrose breakdown pathways, probably induced by diet imbalance.
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Introduction
Obesity is a major public health concern resulting from a mixture of environmental, genetic,
neural and endocrine factors [1]. The distal gastrointestinal tract harbors>1014 microorgan-
isms with significant differences in the taxonomy and concentration of the bacteria along the
digestive track reflecting major variations in the environmental niche [1]. There are complex
links between the digestive microbiota and obesity, and a new area of research has emerged
based on the links between intestinal microbiota, weight change, the relief of malnutrition, and
the use of antibiotics and probiotics [2]. The highest bacterial concentration, approximately
1011–12 microorganisms per gram of content, resides in the colon and is mainly comprised of
anaerobes [1]. In contrast, much lower bacterial concentrations, approximately 103–4 microor-
ganisms per mL of content, are present in the upper two-thirds of the small intestine [3]. Lacto-
bacillus sp., Escherichia coli and Enterococci have been found as the predominant species in the
duodenum and jejunum [3,4]. Probiotics and antibiotics can alter the intestinal flora, and the
role of Lactobacillus, Bifidobacteria or Enterococcus is easier to understand as the duodenojeju-
nal flora contains mostly these species [2,3]. The small intestine is responsible for most nutrient
digestion and absorption by humans. Proteins and lipids are almost completely absorbed
before entering the large intestine, along with simple sugars, such as glucose, very few disaccha-
rides (lactose and sucrose), and a portion of starch [5]. In the colon, microorganisms ferment
undigested starch (including resistant starch), unabsorbed sugars, plant cell wall polysaccha-
rides and mucins into the short-chain fatty acids (SCFAs) butyrate, acetate and propionate,
which provide approximately 10% of the calories humans absorb [5,6].
Human microbiota projects are being initiated throughout the world, with the goal of corre-
lating human physiological phenotypes with the structures and functions of their indigenous
microbial communities [7,8]. However, the nature of the changes in the intestinal microbiota
associated with obesity is a subject of controversy, and major discrepancies between different
studies have appeared [1]. The development of experimental models to study the relationship
between gut microbiota and obesity has mostly been based on the study of feces [7]. Recently,
we showed that fecal analysis may not be the optimal method to examine the link between obe-
sity and gut flora and that more focus should be given to the microbiota of the small intestine
because this is where the calories are absorbed. However, to date, few studies have tested the
microbiota of the upper intestinal track [9], and to the best of our knowledge, this compartment
of microbiota has been explored by metagenomic analysis only once in humans, namely on
ileostomy effluent samples collected from individuals who have had an ileostomy for 20 years
[10]. We report here the first metagenomic analysis of duodenal samples from obese and normal
volunteers to examine the microbial population and functions of upper intestinal microbiota.
Materials and Methods
Human Subjects
Duodenal samples from healthy volunteers were collected in the framework of a clinical study
(mrtm02.01) on gastrointestinal lipolysis performed with a solid-liquid test meal. Duodenal
samples from obese patients (BMI>28) were collected under similar test meal conditions.
These studies were not initially designed for studying gut microbiota at the time they were per-
formed, and samples had been kept frozen in sterile conditions at -80°C since 2003.
Ethics statement
Experiments were performed at the CPCET (Centre de Pharmacologie Clinique et d'Etudes
Thérapeutiques, La Timone Hospital, Marseille) after the clinical protocol was accepted by the
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institutional review board of the local ethics review committee (CCPPRB, Comité Consultatif
de protection des Personnes dans la Recherche Biomédicale, Marseille). Written informed con-
sent was obtained from all participating patients.
Test meal
The mixed solid/liquid meal used for the clinical studies contained 80 g string beans, 90 g beef,
70 g French fries, 10 g butter, 15 mL olive oil, 5 mL sunflower oil and water for a total volume
of 700 mL. Before mixing, the string beans, the beef and the French fries were put into a mincer
with 2 mm holes.
Experimental setup for collecting duodenal samples
After an overnight fasting period, the volunteers/patients were intubated with a single-lumen
duodenal tube (outside diameter 5 mm) and a separated single-lumen gastric tube (outside
diameter, 3 mm) as previously described [11]. The distal end of the duodenal tube was placed
at the ligament of Treitz for aspiration of duodenal contents (-10 cm H2O). The test meal con-
taining a non-abasorbable marker (PEG4000) was introduced into the stomach through the
gastric tube using a 50 mL syringe over a period of 5 minutes. The duodenal fluid was then col-
lected continuously by aspiration and fractioned every 15 minutes. Duodenal samples (1 mL)
were immediately mixed with 1 mL glycerol and 40 μL protease inhibitors and frozen in liquid
nitrogen before storage at -80°C. The samples selected for the present study were all collected
at an average time of 90 minutes after meal intake.
16S rDNA V6 Pyrosequencing
Total DNA was extracted from the samples using a method modified from the Qiagen stool
procedure [QIAamp DNA Stool Mini Kit (Qiagen, Courtaboeuf, France)] [12].
Primers were designed to produce an amplicon length (576 bp) that was approximately
equivalent to the average length of reads produced by the GS FLX Titanium (Roche Applied
Science, Meylan, France) as previously described [12,13]. The primer pairs commonly used for
gut microbiota were assessed in silico for sensitivity to sequences from all phyla of bacteria in
the complete Ribosomal Database Project (RDP) database. Based on this assessment, the bacte-
rial primers 917F and 1391R were selected. The V6 region of 16S rRNA V6 was pyrosequenced
with unidirectional sequencing from the forward primer with one-half of a GS FLX Titanium
PicoTiterPlate Kit 70×75 per patient with the GS Titanium Sequencing Kit XLR70 after clonal
amplification with the GS FLX Titanium LV emPCR Kit (Lib-L).
Metagenomic deep sequencing using Illumina MiSeq
Five samples of weight gain individuals and five samples of normal weight individuals were
extracted using the protocol 1 and were amplify by illustra GenomiPhi V2 DN Amplification
Kit(GE Healthcare Bio-Sciences Corp. Piscataway, NJ 08855–1327, USA) to get enough geno-
mic DNA. The DNAg of samples were then pooled and sequenced on the MiSeq Technology
(Illumina, Inc, San Diego CA 92121, USA) with paired end and barcode according to the Nex-
tera XT library kit (Illumina). The genomic DNA was quantified by a Qubit assay with the high
sensitivity kit (Life technologies, Carlsbad, CA, USA) and dilution was performed to require 1ng
of each sample as input. The « tagmentation » step fragmented the genomic DNA. Then limited
cycle PCR amplification completed the tags adapters and introduce dual-index barcodes. After
purification on Ampure beads (Lifetechnolgies, Carlsbad, CA, USA), the libraries were then nor-
malized on specific beads according to the Nextera XT protocol (Illumina). Normalized libraries
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are pooled into a single library for sequencing on the MiSeq. The pooled single strand library
was loaded onto the reagent cartridge and then onto the instrument along with the flow cell.
Automated cluster generation and paired-end sequencing with dual index reads was performed
in a single 39-hour run in a 2x250-bp. A total information of 6.5 G bases was obtained from a
695K/mm2 density with 91.17% (14,763,000 clusters) of the clusters passing quality control
(QC) filters. Within this pooled run, the average index representation was determined 3.80%.
The average 478, 239 paired end reads were filtered according to read quality.
16S rRNA pyrosequencing analysis
The 16S raw data for all samples was processed and compared using QIIME pipeline 1.7.0 [14],
which contains a suite of Python scripts for data analyses. The raw reads were demultiplexed
with split_libraries.py and were trimmed using a minimum read length of 150 bp and an aver-
age quality score of 30. One mismatch was allowed along the primer sequences. The number of
homopolymers authorized in a sequence was limited to 6. The high quality reads were classified
to their corresponding operational taxonomic unit (OTU) at 97% similarity using the open-ref-
erence OTU picking strategy in QIIME pipeline. The representative OTU sequences were taxo-
nomically classified using the RDP classifier [15] algorithm implemented in QIIME and using
the most recent Greengene database gg_12_10 (http://greengenes.secondgenome.com/
downloads/database/12_10). The NAST multi-aligner implemented in QIIME performed the
multiple sequence alignment that is used to build phylogenic trees. Before building the phylo-
genic tree, the chimera identification sequence was performed by USEARCH [16]. We also
applied a QIIME random subsampling normalization to the OTU table of samples for the sam-
ple with the fewest read numbers. Moreover, the OTU table of all samples was filtered, discard-
ing all OTUs that did not contain a minimum of three reads. The QIIME results, including
tree, mapping and OTU files, were import into Phyloseq, an R package, for manipulation,
alpha indices determination and graph visualizations. The 16S pyrosequencing raw data has
been submitted to the SRA archive under the accession number SRP059828.
Metagenomic analysis
The metagenomic paired-reads were assessed for quality (minimum average of 25) and assem-
bled using the Panda package [17]. The prodigal software performed the detection of open
reading frames from metagenomic assembled reads (parameter—p = m) data. The KEGG
assignment of the ORFs against the genepep KEGG database was provided by BLASTP, with
an E-value of 10−4, a minimum bit score of 50 and sequence coverage>70. The corresponding
tables from geneID to KO numbers, from KO to EC Enzyme or to pathways numbers, as well
as the KEGG mapper tool (http://www.genome.jp/kegg/mapper.html) were used to build the
different metabolic pathways. The assignment to Cluster of Orthologous Group (COG) was
performed using RPS-Blast against the COG position-specific scoring matrix (PSSM) from the
NCBI Conserved Domain Database, with a minimum E-value of 10−4, a bit score> 50 and
sequence coverage> 70. The blast results were parsed for COG numbers that provided a classi-
fication into the different COG categories. The metagenomic raw data has been submitted to
the SRA archive under the accession number SRP059828.
Statistical analysis
The relative abundance differences between obese and normal populations were analyzed
using the nonparametric (Kruskal-Wallis test) statistical method. For data comparisons, we
used EpiInfo version 6.0 software (Centers for Disease Control and Prevention, Atlanta, GA,
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USA). A p value< 0.05 was considered significant. The raw p-values were adjusted using the
Benjamini-Hochberg correction.
Results
Subject and sample Characteristics
We tested five lean healthy volunteers (3 males) and five obese patients (3 males) (Table 1).
Lean subjects had a BMI of 20.7±2.3 kg/m2 (19–24.5) and a mean age of 29.6 (26–34), whereas
obese subjects had a BMI of 36.8±8.4 kg/m2 (28.3–47.2) and a mean age of 39 (26–54).
Although the variance of BMI in the obese group was high, the difference in BMI between the
two groups was significant (p<0.01) and allowed a clear distinction between lean and obese
subjects, in the absence of body composition data.
At the time of collection of the duodenal samples used for the metagenomic study (90 min
after meal ingestion), no significant difference (p>0.05) in the rate of gastric emptying was
observed between lean (68.5 ± 21.9%) and obese (68.4 ± 25.5%) subjects, who received the
same test meal. In both cases, around two third of the meal had already been emptied from the
stomach and through the duodenum together with gastric, pancreatic and biliary secretions.
Changes in microbiota profile due to differences in gastric emptying were therefore unlikely.
Table 1. Patient characteristics.
Subjects Sampling date Age Sex Body Mass Index
Lean, healthy volunteers 11-Mar-03 28 F 19
02-Apr-03 26 F 24.5
10-Apr-03 34 M 19
30-Apr-03 29 M 20.3
15-May-03 31 M 20.8
Obese patients 28-Mar-03 30 M 36
10-Apr-03 26 F 29.2
24-Apr-03 37 F 43.5
07-May-03 54 M 28.3
28-May-03 48 M 47.2
doi:10.1371/journal.pone.0137784.t001
Table 2. Standard alpha diversity estimates.
Sample description No of high quality reads No. of Observed OTUs (k = 3) Chao (k = 3) Shannon (k = 3)
Obese 1 25301 533 596 4.30
Obese 2 35055 528 669 4.27
Obese 3 31769 375 461 4.52
Obese 4 33792 561 628 4.17
Obese 5 25189 559 644 4.67
Normal 1 25762 469 586 4.00
Normal 2 30340 591 655 4.30
Normal 3 25942 556 648 4.30
Normal 4 27069 317 365 4.41
Normal 5 25972 398 496 4.37
Standard alpha diversity estimates were performed from the ﬁltered OTU table.
In this way, the OTUs with less than 3 reads were removed from the initial OTU table.
doi:10.1371/journal.pone.0137784.t002
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Duodenal gut microbiota
The microbial structure and composition of the duodenal gut microbiota was characterized by
a 16S rRNA pyrosequencing approach. The average 16S rRNA pyrosequencing read length was
374 bp. Table 2 summarizes the number of pyrosequencing-trimmed reads obtained for each
of the ten samples. The analysis of the high-quality trimmed reads, which included a random
subsampling normalization, indicated that the gut microbiota of the obese and normal individ-
uals was composed of 11 bacterial phyla (Fig 1). Although we observed an inter-individual vari-
ability in taxonomic composition, Firmicutes and Actinobacteria were the most predominant
phyla of the bacterial composition of the duodenal microbiota within obese and control groups
(Fig 1). These predominant phyla were followed by less abundant ones, including Proteobac-
teria, Fusobacteria, TM7, Bacteroidetes and Tenericutes. Overall, the phylum taxonomic profile
was very similar between the obese and control groups (S1 Fig), with small differences for Fir-
micutes (62% in the control group vs 67% in the obese group; p = 0.91) and Proteobacteria
(9.5% in the control group vs 4% in the obese group; p = 0.25). Compared with distal gut
microbiota, the microbiota of the duodenal site showed major differences exemplified by the
almost complete absence of the Bacteroidetes phylum (only present at 0.2%) and by the sub-
stantial abundance of Actinomyces and Streptococcus OTUs. We merged OTUs at the genus
(Fig 2) and species (S2 Fig) taxonomic ranks to compare the abundance levels for the individu-
als within each sample category. This comparison between the obese and control categories did
not show any significant differences for all tested species and genera except for the Rubrobacter
genus (p = 0.019).
With more observed species, the global richness of the obese group was higher than the con-
trol group as shown by rarefaction curves (S3 Fig). However, this difference was not significant
using a 3% OTU distance and the Kruskal-Wallis statistical test. In addition, the alpha diversity
Simpson indices indicated a weak biodiversity, as only a few abundant OTUs dominated the
microbiota composition that mainly comprised Streptococcus (30–32%), Actinomyces (12–
17%), Propionibacterium (3–8%) and Granulicatella (2–4%) genera. The many remaining
OTUs were in weak abundance (most of them< 1%). We also investigated the distribution of
aerobic and facultative anaerobic genera residing in the duodenal microbiota of the obese and
control groups using the taxonomic classification provided by 16S amplicon analysis. The dif-
ference in aerobic genus counts between the obese and control groups was not significant, with
55 and 52 genera identified, respectively. Likewise, the difference in anaerobic genus counts
Fig 1. Phylum taxonomic classification.Ob, Obese individual; Norm, Normal weight individual.
doi:10.1371/journal.pone.0137784.g001
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was also not significant, with 55 and 52 genera identified for the obese and control groups,
respectively. However, the relative abundance of aerobic and anaerobic genera indicated a sig-
nificant difference between the obese and control groups (Chi-square test; p< 0.001). Com-
pared with the control group, the obese group presented a higher proportion of anaerobic
genera and a lesser proportion of aerobic genera (Fig 3).
Duodenal gut microbiome
Using a metagenomic approach, we investigated the functional capabilities of the duodenal
microbiome within obese and control samples. We performed COG (Table 3) and KEGG
metabolism category classifications (Table 4). The percentage of COG assigned to carbohydrate
Fig 2. Genus relative abundance by individual.Obese and normal weight individuals are represented by red and blue nodes, respectively. A colored node
corresponds to the identification of a genus for one individual. The node size is proportional to the normalized genus abundance.
doi:10.1371/journal.pone.0137784.g002
Duodenal Microbiota
PLOS ONE | DOI:10.1371/journal.pone.0137784 September 10, 2015 7 / 15
metabolism tended to be lower in the obese group than that in the control group (S4 Fig)
(p = 0.15). In contrast, the proportion of COG assigned to lipid metabolism tended to be
higher in the obese group than in the control group (p = 0.1). The KEGG analysis gave results
equivalent to those of the COG classification, including those for lipid and carbohydrate
metabolisms.
We investigated the type and the relative abundance of the enzymes involved in lipid path-
ways, including fatty acid biosynthesis and degradation. In the fatty acid degradation pathway
(S5 Fig), we found that the Acyl-CoA dehydrogenase (EC 1.3.99-) targeting the early enzymatic
reaction of fatty acid beta-oxidation was enriched (COG and KEGG analyses) in the obese
group compared with the control group (p = 0.0018). The degradation of a fatty acid requires
multiple repetitions of the fatty acid beta-oxidation process (Lynen helix) that leads to the
removal each round of two carbon atoms from the acyl chain and to the release of one Acetyl-
CoA molecule for the Krebs’ cycle. Moreover, other Acyl-CoA dehydrogenases (EC:1.3.3.6 and
Fig 3. Relative abundance of anaerobic and aerobic genera of the duodenal microbiota. The source black nodes are the obese and the normal weight
groups (five individuals by group). The blue and red nodes are the aerobic and anaerobic genera identified in the groups, respectively. The genus node is
linked by an edge to it source node. The genus relative abundance is given by the node size. Finally, two genera shared by the obese and normal weight
groups are linked by an additional edge. The Cytoscape network visualization tool version 3.1.0 was used for building this figure.
doi:10.1371/journal.pone.0137784.g003
Duodenal Microbiota
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EC:1.3.8.3) targeting specific acyl chain lengths but catalyzing the same enzymatic reaction
were only detected in the obese group.
The fatty acid biosynthesis pathway (S6 Fig) highlighted the presence of many enoyl-[Acyl car-
rier protein] reductase enzymes, including FabK, FabI, FabL. These enzymes are components of
the type II fatty acid synthase system (Fas) and catalyze the terminal reaction in the fatty acid elon-
gation cycle. The diversity of the enoyl reductase enzymes results from different substrate specifici-
ties that can enhance the regulation and the distribution of the products synthetized in the
pathway. In our data, FabK was enriched in the control (p = 0.027) compared to the obese group;
FabL and FabI were only detected in the control group. In addition, the relative abundance of the
fatty acid synthase (Fas) tended to be higher in the control group (p = 0.07). An inspection of the
glycerophospholipid metabolism pathway revealed the presence of phospholipase A1 (EC:3.1.1.32)
only in control group (3 of 5 individuals, p = 0.05). An analysis of the corresponding protein best
BLAST hits indicated that the sequences were homologous to the outer membrane phospholipase
A (OMPLA), which is widespread among gram-negative bacteria and is known as a virulence fac-
tor in Campylobacter coli [18] andHelicobacter pylori [19]. In addition, we found that the duodenal
microbiota of the obese group showed a reduced abundance of genes encoding sucrose phosphory-
lase (EC:2.4.1.7) (p = 0.015) and 1,4-alpha-glucan branching enzyme (EC:2.4.1.18) (p = 0.046),
suggesting an alteration of the sucrose/glycogen balance in the obese flora.
Discussion
We used pyrosequencing of 16S rRNA amplicons and metagenomic analysis to compare the
duodenal microbiota in obese individuals to normal weight individuals. Although our samples
were collected under similar conditions of test meal and gastric emptying they were taken from
Table 3. COG assignment by category and individual.
COG Category (%) VS1 VS2 VS3 VS4 VS5 OB1 OB2 OB3 OB4 OB5
RNA_processing_and_modiﬁcation 0 0 0 0.03 0.02 0.13 0.17 0.13 0.02 0.09
Chromatin_structure_and_dynamics 0.02 0.05 0.02 0.03 0.02 0 0.11 0.05 0 0.04
Energy_production_and_conversion 7.59 7.92 9.59 8.03 7.59 8.4 7.75 6.6 7.26 9.95
Cell_cycle_control/cell_division_partionning 1.16 0.98 1.18 1.23 1.07 1.2 0.88 1.09 1.35 1.72
Amino_acid_metabolism_and_transport 9.5 11.28 11.7 10.38 9.65 11.03 9.8 10.3 10.93 9.73
Nucleotide_metabolism_and_transport 3.19 4.13 4.77 4.58 3.42 4.31 3.06 3.74 3.84 3.52
Carbohydrate_metabolism_and_transport 9.71 7.84 9.79 8.42 7.33 7.96 6.73 7.69 7.83 7.5
Coenzyme_metabolism_and_transport 4.23 4.86 5.67 4.84 4.66 4.94 4.25 4.33 5.01 3.17
Lipid_metabolism_and_transport 3.31 2.9 3.46 3.22 2.99 2.8 3.12 3.47 3.64 3.04
Tranlsation_ribosomal_structure_and_biogenesis 9.22 8.83 10.65 9.87 9.74 8.58 8.33 9.34 9.73 10.85
Transcription 5.77 5.46 8.07 5.48 5.45 5.11 5.82 6.12 5.12 5.45
Replication_recombination_and_repair 7.73 8.9 10.45 7.9 8.72 7.69 9.27 9.46 8.57 10.08
Cell_wall/membrane/envelope_biogenesis 5.96 4.48 6.59 5.55 5.73 5.2 6.04 5.79 5.97 4.5
Cell_motility 0.85 0.47 0.54 0.35 0.88 0.71 0.66 0.66 0.52 0.6
Post/translational_modiﬁcation,_protein_turnover,_chaperone_ 4.14 4.32 4.83 4.03 3.56 4.18 4.06 4.38 4.28 3.9
Inorganic_ion_transport_and_metabolism 4.87 4.6 5.75 4.29 5.18 5.16 5.35 4.23 4.47 4.5
Secondary_structure 1.25 1.52 1.68 1.13 1.29 0.84 2.04 1.62 1.4 1.54
General_functional_prediction_only 8.7 9.01 10.47 8.87 9.48 9.6 8.31 8.73 8.59 8.58
Function_unknown 5.63 5.14 6.07 4.93 5.25 5.25 5.49 4.35 4.33 4.85
Signal_transduction 3.38 3.29 4.47 3.68 3.77 2.71 4.25 4.1 3.22 3.39
Intracellular_trafﬁcing_and_secretion_vesicular_transport 1.75 1.77 1.56 1.1 2.05 1.96 1.52 1.39 1.5 0.9
Defense_mechanisms 2.01 2.19 2.64 2.03 2.05 2.13 2.87 2.15 2.33 1.97
doi:10.1371/journal.pone.0137784.t003
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Table 4. KEGG assignment using BRITE hierarchical classification and by sample group.
Control group % Obese group %
Metabolism
Amino_Acid_Metabolism 13.26 13.03
Biosynthesis_of_Other_Secondary_Metabolites 1.69 1.65
Carbohydrate_Metabolism 7.65 7.34
Energy_Metabolism 8.65 8.46
Glycan_Biosynthesis_and_Metabolism 3.64 3.92
Lipid_Metabolism 2.38 2.63
Metabolism_of_Cofactors_and_Vitamins 8.37 8.44
Metabolism_of_Other_Amino_Acids 2.72 2.77
Metabolism_of_Terpenoids_and_Polyketides 1.93 2.34
Nucleotide_Metabolism 4.41 4.12
Xenobiotic_Biodegradation_and_Metabolism 2.21 2.23
Environmental_Information_Processing
Membrane_Transport 8.74 7.81
Signaling_Molecules_and_Interaction 0.02 0.02
Signal_Transduction 2.71 3
Genetic_Information_Processing
Folding,_Sorting_and_Degradation 3.01 3.55
Replication_and_Repair 7.1 7.35
Transcription 2.61 1.95
Translation 9.76 9.24
Cellular_Processes
Cell_Communication 0 0.02
Cell_Growth_and_Death 1.55 1.91
Cell_Motility 0.84 0.81
Transport_and_Catabolism 0.72 0.7
Human_Diseases
Cancers 0.35 0.33
Cardiovascular_Diseases 0.02 0.05
Endocrine_and_Metabolic_Diseases 0.2 0.25
Immune_Diseases 0.07 0.09
Infectious_Diseases 2.45 2.52
Neurodegenerative_Diseases 1.06 0.97
Substance_Dependence 0 0.03
Organismal_Systems
Development 0 0.02
Digestive_System 0.29 0.49
Endocrine_System 0.59 0.74
Environmental_Adaptation 0.41 0.42
Excretory_System 0.01 0.12
Immune_System 0.07 0.11
Nervous_System 0.4 0.35
Sensory_System 0.1 0.2
doi:10.1371/journal.pone.0137784.t004
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a study that was not initially designed for studying gut microbiota, they were kept frozen in
sterile conditions at -80°C, eliminating the possibility of contamination. Moreover, before anal-
yses, we verified that all of our samples had a good DNA load. To date, most of the 16S rRNA
sequencing- and metagenomic-based studies have analyzed the distal part of the gut using
feces and reported differences in the relative abundances of bacterial communities in the gut
microbiota of obese versus normal weight people [20]. However, it is noteworthy that the cur-
rent 16S rDNA studies of gut microbiota within obese populations were not able to detect bac-
terial concentrations that were below 107 organisms per gram of feces because of sequencing
capability limitations [21,22]. As a result, these sequencing-based methods are generally not
able to access the complete richness of a feces sample and are biased by the heterogeneity of the
copy number of the 16S rRNA gene that is present in an individual bacterial genome, which
can lead to an overestimation of bacterial proportions [1,23]. Indeed, the characterization of
the 1011–12 microorganisms per gram of feces that was used in these studies remains superficial.
In contrast with the distal human gut, the bacterial concentrations in the duodenum reach only
103–4 cells per mL of content [3]. Because of the lower bacterial concentration present in the
duodenum, we were able to characterize the full species richness of samples by deep sequenc-
ing, as shown in the rarefaction curves (S3 Fig). Indeed, when the sequencing effort is adequate
to collect the complete species richness of a sample, the curve tends to the asymptote.
A limitation of our study was that we used 12-year-old frozen samples. Excessive degrada-
tion of DNA reduces the efficiency of shotgun sequencing [24] and previous studies showed
that storing conditions of stool samples modestly affect the structure of their microbial com-
munity [25]. It was found that the structure of microbial community is not affected when fecal
samples are freeze and stored immediately [25]. Lauber et al. reported that the phylogenetic
structure of the microbiota did not significantly differ between three and fourteen day old fecal
samples stored at a range of temperatures [26]. Moreover it was found that fecal samples kept
at -80°C for up to six months also retain a microbiota that was similar in composition to a
fresh sample from that individual [27]. Based on these, we believe that the quality and the
microbial community of our samples remained stable as all our samples were immediately fro-
zen after collection at −80°C and were never thawed and refreeze.
We found that the duodenal microbiota presents important differences compared to the
microbiota of feces. Indeed, the predominant phyla of the duodenal microbiota were Firmicutes
and Actinobacteria, whereas Bacteroidetes were almost completely absent. This may be related
to a limited availability of mucin as carbon source for Bacteroidetes, which are characterized by
a high number of genes coding mucin-degrading enzymes like glycosyl hydrolases, proteases/
peptidases, sulfatases and sialidases/neuraminidases [28]. Indeed, the mucin layer is much
thinner in the small intestine than in the stomach and the colon [28].
Approximately 60% of the genera OTUs belonged to Streptococcus, Actinomyces, Propioni-
bacterium and Granulicatella. Similarly, in a recent study, the phylogenetic mapping of the
small intestinal metagenome of three different ileostomy effluent samples from a single indi-
vidual indicated that Streptococcus sp., Escherichia coli, and Clostridium sp. were most abun-
dant in the small intestine [10]. Similarly, in a culture-based study in infants, Actinobacteria
and Firmicutes were found to be the dominant phyla in ileostomy samples, whereas Bacteroi-
detes were only detected following the reversal of the ileostomy in the final fecal sample [29]. In
contrast, studies of stool microbiota revealed that Firmicutes and Bacteroidetes were the pre-
dominant phyla [30–32]. Moreover, we found that obese individuals had a significantly higher
proportion of anaerobic bacteria in their duodenal microbiota. This difference was mostly asso-
ciated with the presence of Veillonella, Bulleidia and Oribacterium. Previously, Veillonella was
detected significantly more in the gut microbiota of children with type 1 diabetes [33]. Veillo-
nella are able to ferment glucose and lactate to propionate, acetate and succinate [33].
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The Acyl-CoA dehydrogenase (FAD) involved in the first enzymatic reaction of fatty acid
beta-oxidation was enriched in the obese group. This high occurrence of Acyl-CoA dehydroge-
nase in obese subjects might be associated with a higher beta-oxidation capacity and energy
mobilization (Fig 4). Conversely, a higher production of fatty acids would be favored in normal
subjects with both a low occurrence of FAD and a high occurrence of OMPLA phospholipase
A1. Indeed, OMPLA is particularly active in E. coli cells with a ‘fad’mutation and a perturbed
cell envelope structure [34]. The E. coli fad strain does not perform beta-oxidation and is charac-
terized by an appreciable turnover of phospholipids and sizeable amounts of fatty acids resulting
from phospholipid hydrolysis [34]. If one assumes that obese patients have an excessive uptake
of food and particularly fat, their intestinal microbiota may have adapted to high levels of die-
tary fats and free fatty acids released upon gastrointestinal lipolysis [35]. Free fatty acids could
thus be used as a carbon and energy source for microbial growth. High fat loads are also associ-
ated with increased endotoxemia, suggesting that fat and its lipolysis products have a deleterious
effect on gut microbiota, leading to LPS release [36–38]. The harvest and degradation of fatty
acids by bacteria might be viewed as an adaptive response to their antibacterial effects.
Duodenal sensing mechanisms linked to the release of fatty acids and their levels might also
be impacted by microbiota. Fatty acids released in the upper duodenum trigger the release of
Fig 4. Fatty acid beta-oxidation by duodenal microbiota in obese individuals. The degradation of fatty acids involves their conversion into Acyl-CoA
followed by multiple repetitions of the fatty acid beta-oxidation cycle that leads to the removal each round of two carbon atoms from the acyl chain and to the
release of one Acetyl-CoA molecule entering in the Krebs’ cycle. Four key enzymes are involved in the beta-oxidation process, including Acyl-CoA
dehydrogenase (FAD), enoyl CoA hydratase, 3-hydroxy acyl CoA dehydrogenase and 3-ketoacyl CoA thiolase. FAD, the first enzyme of fatty acid beta-
oxidation, was found to be enriched in the microbiota of obese subjects, suggesting a higher beta-oxidation capacity and energy mobilization in these
subjects.
doi:10.1371/journal.pone.0137784.g004
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CCK which first stimulates pancreatic secretion and thus digestion [39]. CCK has however a
dual function and also acts as a satiety agent together with other gut hormones like GLP-1 and
PYY [40]. It has been suggested that obesogenic microbiota induced high-fat feeding may alters
CCK action and lead to dysregulation of glucose homeostasis [41,42]. The mechanism by
which obesogenic microbiota may induce CCK resistance has not been explored yet in humans.
One hypothesis could be that the microbiota of obese patients may lower fatty acid levels by
degrading them more efficiently. This could impact the fatty acid-induced release of gut hor-
mones involved in satiety mechanism and regulation of glucose homeostasis.
In conclusion, the low bacterial concentration and particular taxonomic composition of the
duodenojejunal microbiota makes the evaluation of its variation by stool sample analysis
extremely difficult. To the best of our knowledge, this is the first time that human duodenal
samples have been analyzed by metagenomic techniques, and we found that the duodenal
microbiota of obese individuals shows an increased capacity to degrade fatty acids, whereas the
flora of control individuals shows an increased capacity to store fatty acids. Because the con-
centration of living bacteria is much higher in fermented products used as probiotics than in
the duodenal flora (109 vs 105 microbes per mL, respectively), the impact of probiotics is proba-
bly more important on the duodenal than on the distal gut microbiota.
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